Atherosclerosis
Volume 204, Issue 2 , Pages 619-623 , June 2009

Association between metabolic syndrome and carotid atherosclerosis in individuals without diabetes based on the oral glucose tolerance test

  • Nobukazu Ishizaka

      Affiliations

    • Department of Cardiovascular Medicine, University of Tokyo, Graduate School of Medicine, Hongo 7-3-1 Bunkyo-ku, Tokyo 113-8655, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 3 3815 5411x37156; fax: +81 3 5842 5586.
    • ,
  • Yuko Ishizaka

      Affiliations

    • Center for Multiphasic Health Testing and Services, Mitsui Memorial Hospital, Tokyo, Japan
    • ,
  • Minoru Yamakado

      Affiliations

    • Center for Multiphasic Health Testing and Services, Mitsui Memorial Hospital, Tokyo, Japan
    • ,
  • Eiichi Toda

      Affiliations

    • Center for Multiphasic Health Testing and Services, Mitsui Memorial Hospital, Tokyo, Japan
    • ,
  • Kazuhiko Koike

      Affiliations

    • Department of Infectious Diseases, University of Tokyo, Graduate School of Medicine, Tokyo, Japan
    • ,
  • Ryozo Nagai

      Affiliations

    • Department of Cardiovascular Medicine, University of Tokyo, Graduate School of Medicine, Hongo 7-3-1 Bunkyo-ku, Tokyo 113-8655, Japan

Received 31 July 2008 ,Revised 20 October 2008 ,Accepted 21 October 2008.

References 

  1. Iso H, Sato S, Kitamura A, et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke. 2007;38:1744–1751
  2. Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH, Yoon BW. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke. 2006;37:466–470
  3. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J. The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland. Stroke. 2008;39:1078–1083
  4. Fadini GP, Coracina A, Inchiostro S, Tiengo A, Avogaro A, de Kreutzenberg SV. A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. Eur J Cardiovasc Prev Rehabil. 2008;15:190–196
  5. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289–2304
  6. Murakami S, Otsuka K, Hotta N, et al. Common carotid intima-media thickness is predictive of all-cause and cardiovascular mortality in elderly community-dwelling people: Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) study. Biomed Pharmacother. 2005;59(Suppl 1):S49–53
  7. Mannami T, Baba S, Ogata J. Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med. 2000;160:2297–2303
  8. Ishizaka N, Ishizaka Y, Hashimoto H, et al. Metabolic syndrome may not associate with carotid plaque in subjects with optimal, normal, or high-normal blood pressure. Hypertension. 2006;48:411–417
  9. Hsu PF, Chuang SY, Cheng HM, et al. Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: a community-based study. Diabetes Res Clin Pract. 2008;79:461–467
  10. Stern MP, Williams K, Hunt KJ. Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease. Atheroscler Suppl. 2005;6:3–6
  11. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis. 2005;181:381–388
  12. Ishizaka N, Ishizaka Y, Takahashi E, et al. Association between insulin resistance and carotid arteriosclerosis in subjects with normal fasting glucose and normal glucose tolerance. Arterioscler Thromb Vasc Biol. 2003;23:295–301
  13. Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300:197–208
  14. Paras E, Mancini GB, Lear SA. The relationship of three common definitions of the metabolic syndrome with sub-clinical carotid atherosclerosis. Atherosclerosis. 2008;198:228–236
  15. Vaidya D, Szklo M, Liu K, et al. Defining the metabolic syndrome construct: Multi-Ethnic Study of Atherosclerosis (MESA) cross-sectional analysis. Diabetes Care. 2007;30:2086–2090
  16. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716
  17. Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066–3072
  18. Leoncini G, Ratto E, Viazzi F, et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Intern Med. 2005;257:454–460
  19. Kawamoto R, Tomita H, Ohtsuka N, Inoue A, Kamitani A. Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness. J Atheroscler Thromb. 2007;14:78–85
  20. Tzou WS, Douglas PS, Srinivasan SR, et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol. 2005;46:457–463
  21. Pannier B, Thomas F, Bean K, et al. The metabolic syndrome: similar deleterious impact on all-cause mortality in hypertensive and normotensive subjects. J Hypertens. 2008;26:1223–1228

PII: S0021-9150(08)00760-0

doi: 10.1016/j.atherosclerosis.2008.10.022

Atherosclerosis
Volume 204, Issue 2 , Pages 619-623 , June 2009

Article Tools

* Image Usage & Resolution